Item | Gene | Dietary treatments1 | SEM | P-value |
---|
Basal2 | inSeMP2 | orgSeMP2 | Â | Â |
---|
Duodenum | IL10 | 1.04a | 1.61b | 1.03a | 0.179 | 0.047 |
IL17a | 1.09 | 1.73 | 0.94 | 0.223 | 0.069 |
TLR4 | 1.15ab | 1.90b | 0.87a | 0.234 | 0.026 |
Jejunum | MUC2 | 1.34ab | 1.49b | 0.70a | 0.211 | 0.038 |
SLC15A1 | 1.13 | 0.73 | 1.13 | 0.153 | 0.099 |
FABP2 | 1.22b | 0.67a | 1.13b | 0.149 | 0.037 |
SLC2A2 | 1.2 | 0.72 | 1.07 | 0.15 | 0.095 |
Ileum | CLDN3 | 0.84ab | 1.38b | 0.64a | 0.347 | 0.008 |
MUC2 | 0.72 | 0.73 | 0.91 | 0.189 | 0.089 |
DIO1 | 0.35a | 1.24b | 0.79ab | 0.169 | 0.011 |
- InSeMP mushroom powder supplemented with inorganic selenium, orgSeMP mushroom powder enriched with organic selenium, SLC15A1/PEPT1 peptide transporter 1, FABP2, fatty acid binding protein 2, SLC2A2/GLUT2 glucose transporter 2, IL10 interleukin 10, MUC2 mucin 2, IL17 interleukin 17, TLR4 toll like receptor 4, CLDN3 claudin 3, DIO1Â deiodinase type 1
- 1Dietary treatments: (1) Basal diet; (2) basal diet + unenriched mushroom powder (inSeMP) containing an inorganic selenium (selenite) content of 0.3 mg/kg feed and a β-glucan content of 650 mg/kg feed; (3) basal diet + selenium enriched mushroom powder (orgSeMP) containing an organic selenium (selenocysteine) content of 0.3 mg/kg feed and a β-glucan content of 650 mg/kg feed
- 2A total of 8 replicates were used per treatment
- a−bMean values within a row with unlike superscript letters were significantly different (P < 0.05)